Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.

about

From remission to cure: bypass or detour?

P2860

Q49382624-A68B9CCF-40F0-49FD-807E-7F0D1623618A

P2860

Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.

Item

http://www.wikidata.org/entity/Q47598339

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Durable graft-versus-leukaemia ...... leukaemia and myelodysplasia.

@en

Durable graft-versus-leukaemia ...... leukaemia and myelodysplasia.

@nl

type

Item

label

Durable graft-versus-leukaemia ...... leukaemia and myelodysplasia.

@en

Durable graft-versus-leukaemia ...... leukaemia and myelodysplasia.

@nl

prefLabel

Durable graft-versus-leukaemia ...... leukaemia and myelodysplasia.

@en

Durable graft-versus-leukaemia ...... leukaemia and myelodysplasia.

@nl

P1476

Durable graft-versus-leukaemia ...... leukaemia and myelodysplasia.

@en

P2093

Caroline Besley

http://www.w3.org/2001/XMLSchema#string

David Taussig

http://www.w3.org/2001/XMLSchema#string

Heather Oakervee

http://www.w3.org/2001/XMLSchema#string

Jamie D Cavenagh

http://www.w3.org/2001/XMLSchema#string

Matthew Smith

http://www.w3.org/2001/XMLSchema#string

Sandra Hassan

http://www.w3.org/2001/XMLSchema#string

Shah-Jalal Sarker

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

Nonparametric Estimation from Incomplete Observations

Myelodysplastic syndromes: Contemporary review and how we treat.

Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia.

Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen.

Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation.

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings

P304

346-355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14980

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P50

John G Gribben

Jeff K Davies

P577

2017-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29076145

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

lymphocyte

Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.

about

P2860

P2860

Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921